BioSpace News Archive

Diverse insights provided by expert Board members to accelerate company direction

Anixa Biosciences, Inc. announced the acceptance of an abstract at the 34th Annual Meeting of the Society for Immunotherapy of Cancer A poster presentation will include data from ongoing studies utilizing Cchek™, the company’s artificial intelligence driven cancer detection technology.

The Industry Relations Committee represents all aspects of Biofabrication including roadmap, technologies, cell biology, large scale manufacturing, regulation, and commercialization

Altavant Sciences, a clinical-stage biopharmaceutical company focused on patient-centric drug development in rare respiratory diseases, announced mechanistic preclinical pharmacodynamic and Phase 1 data supporting once-daily dosing of rodatristat ethyl for the treatment of pulmonary arterial hypertension (PAH).

MYOS CEO Joseph Mannello to Speak at the ‘Innovation Showcase’ on November 8 at 12:30pm ET

Excellent Safety Profile and Improvements in Clinically Relevant Secondary Endpoints (Endoscopy and Histology) Support Further Development by a Partner

National Institutes of Health awards contract for CRISPR-based disease modeling in iPS cell lines associated with Alzheimer’s, Stem cell pioneer Bill Skarnes joins advisory board

Webcast scheduled for Wednesday, November 6th at 11:30 a.m. Eastern Time

First Pivotal Study to Investigate Permanent Vascular Implant as a Treatment for Post-Angioplasty Dissections in Arteries Below the Knee (BTK)

“Do Tell” Your Doctor Tool was adapted from a clinically validated questionnaire developed by Duke University, with input from the Parkinson’s community